Providing open-label placebos remotely-A randomized controlled trial in allergic rhinitis.
<h4>Background</h4>Placebos can reduce physical symptoms even when provided with full honesty and disclosure. Yet, the precise mechanisms underlying the effects of "open-label placebos" (OLPs) have remained subject of debate. Furthermore, it is unclear whether OLPs are similarl...
Main Authors: | Tobias Kube, Verena E Hofmann, Julia A Glombiewski, Irving Kirsch |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0248367 |
Similar Items
-
Correction: Providing open-label placebos remotely-A randomized controlled trial in allergic rhinitis.
by: Tobias Kube, et al.
Published: (2021-01-01) -
Why do open-label placebos work? A randomized controlled trial of an open-label placebo induction with and without extended information about the placebo effect in allergic rhinitis.
by: Michael Schaefer, et al.
Published: (2018-01-01) -
DESLORATADINE IN TREATMENT OF ALLERGIC RHINITIS: RESULTS OF RANDOMIZED, PLACEBO_CONTROLLED TRIAL
by: R.T. Saygitov
Published: (2008-01-01) -
DESLORATADINE IN TREATMENT OF ALLERGIC RHINITIS: RESULTS OF RANDOMIZED, PLACEBO_CONTROLLED TRIAL
by: R.T. Saygitov
Published: (2008-01-01) -
Efficacy of Bimin decoction for patients with perennial allergic rhinitis: an open-label non-inferiority randomized controlled trial
by: Jingyi Zhao, et al.
Published: (2019-12-01)